A detailed history of Avantax Advisory Services, Inc. transactions in Argenx Se stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 922 shares of ARGX stock, worth $579,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
922
Previous 860 7.21%
Holding current value
$579,311
Previous $369,000 35.5%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$434.22 - $551.9 $26,921 - $34,217
62 Added 7.21%
922 $500,000
Q2 2024

Aug 09, 2024

BUY
$356.01 - $451.55 $306,168 - $388,333
860 New
860 $369,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.